恶性黑色素瘤细胞形成前列腺素D2的能力与细胞的转移潜能呈负相关。
Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential.
作者信息
Fitzpatrick F A, Stringfellow D A
出版信息
Proc Natl Acad Sci U S A. 1979 Apr;76(4):1765-9. doi: 10.1073/pnas.76.4.1765.
Abstract
B16 malignant melanoma cell lines transform arachidonic acid and its transient metabolite, prostaglandin endoperoxide H2, into prostaglandin D2. The highly metastatic line, B16 F10, forms less prostaglandin D2 compared to the moderately metastatic parent line, B16 F1. Since platelet aggregation may be one factor involved in B16 metastasis and since prostaglandin D2 inhibits platelet aggregation, this prostaglandin could affect the outcome of platelet-tumour interactions, which may contribute ultimately to metastasis. Arachidonic acid metabolism may be another one of the intrinsic biochemical properties of tumor cells that affects their metastasis. Our results suggest that quantitative release of unusual prostaglandins must be considered in this context.
摘要
B16恶性黑色素瘤细胞系将花生四烯酸及其瞬时代谢产物前列腺素内过氧化物H2转化为前列腺素D2。高转移性细胞系B16 F10与中度转移性亲代细胞系B16 F1相比，产生的前列腺素D2较少。由于血小板聚集可能是B16转移涉及的一个因素，且前列腺素D2可抑制血小板聚集，因此这种前列腺素可能影响血小板与肿瘤相互作用的结果，这最终可能有助于转移。花生四烯酸代谢可能是影响肿瘤细胞转移的肿瘤细胞内在生化特性之一。我们的结果表明，在这种情况下必须考虑异常前列腺素的定量释放。
相似文献
1
Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential.
Proc Natl Acad Sci U S A. 1979 Apr;76(4):1765-9. doi: 10.1073/pnas.76.4.1765.
2
Prostaglandins and metastasis.
Symp Fundam Cancer Res. 1983;36:123-31.
3
Prostaglandin D2 is the major prostaglandin of arachidonic acid metabolism in rat bone marrow homogenate.
Prostaglandins. 1980 Jul;20(1):171-6. doi: 10.1016/0090-6980(80)90016-7.
4
Characterization of the biosynthetic pathway of prostaglandin D2 in human platelet-rich plasma.
J Biol Chem. 1982 Dec 25;257(24):14847-53.
5
Preferential generation of prostaglandin D2 by rat and human mast cells.
Kroc Found Ser. 1981;14:239-54.
6
Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
Cancer Res. 1987 Feb 15;47(4):988-91.
7
In vitro prostaglandin biosynthesis in human pregnant uterus from arachidonic acid.
Acta Biol Med Ger. 1978;37(5-6):941-3.
8
Factors influencing metabolism of arachidonic acid in guinea pig gastric mucosa.
Am J Physiol. 1983 Feb;244(2):G131-7. doi: 10.1152/ajpgi.1983.244.2.G131.
9
Enzymatic formation of prostaglandin D2 by rat basophilic leukemia cells and normal rat mast cells.
Biochim Biophys Acta. 1980 Apr 18;618(1):28-34. doi: 10.1016/0005-2760(80)90050-8.
10
Interactions between stimulated platelets and endothelial cells in vitro.
Philos Trans R Soc Lond B Biol Sci. 1981 Aug 18;294(1072):343-53. doi: 10.1098/rstb.1981.0111.
引用本文的文献
1
In Vitro Effects of Selective COX and LOX Inhibitors and Their Combinations with Antineoplastic Drugs in the Mouse Melanoma Cell Line B16F10.
Int J Mol Sci. 2021 Jun 17;22(12):6498. doi: 10.3390/ijms22126498.
2
Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid.
J Clin Invest. 2009 Apr;119(4):954-63. doi: 10.1172/JCI34015. Epub 2009 Mar 9.
3
Inhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancer.
Surg Today. 1998;28(7):740-5. doi: 10.1007/BF02484622.
4
Some mechanisms of local bone destruction by squamous carcinomas of the head and neck.
Br J Cancer. 1981 Mar;43(3):392-401. doi: 10.1038/bjc.1981.60.
5
Thrombocytopenia provoked by carrageenan in rabbits and the inhibitory effect of lysozyme.
Agents Actions. 1982 Dec;12(5-6):657-61. doi: 10.1007/BF01965075.
6
Further observations on mechanisms of bone destruction by squamous carcinomas of the head and neck: the role of host stroma.
Br J Cancer. 1983 Nov;48(5):697-704. doi: 10.1038/bjc.1983.252.
7
Treatment of mouse carcinoma in vivo with a prostaglandin E2 analogue and indomethacin.
Br J Cancer. 1985 Aug;52(2):245-9. doi: 10.1038/bjc.1985.184.
8
[Eicosanoids and phospholipases].
Klin Wochenschr. 1985 Apr 1;63(7):293-311. doi: 10.1007/BF01731973.
9
Cytotoxicity of combinations of prostaglandin D2 (PGD2) and antitumor drugs for B16 melanoma cells in culture.
Invest New Drugs. 1986;4(4):315-23. doi: 10.1007/BF00173504.
10
Perspectives in the treatment of cancer metastasis.
Clin Exp Metastasis. 1987 Apr-Jun;5(2):105-24. doi: 10.1007/BF00058057.
本文引用的文献
1
Prostaglandin levels in normal and transformed baby-hamster-kidney fibroblasts.
Nat New Biol. 1973 May 9;243(123):50-1.
2
The adhesion of thromboplastic tumour emboli to vessel walls in vivo.
Br J Exp Pathol. 1972 Jun;53(3):301-13.
3
Microangiopathic haemolytic anaemia and experimental tumour-cell emboli.
Br J Haematol. 1974 Apr;26(4):651-9. doi: 10.1111/j.1365-2141.1974.tb00508.x.
4
Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages.
Cancer Res. 1974 May;34(5):1074-8.
5
Immune stimulation-inhibition of experimental cancer metastasis.
Cancer Res. 1974 Mar;34(3):491-8.
6
Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease.
Int J Cancer. 1973 May;11(3):704-18. doi: 10.1002/ijc.2910110322.
7
Isolation and properties of intermediates in prostaglandin biosynthesis.
Biochim Biophys Acta. 1973 Dec 20;326(3):448-61. doi: 10.1016/0005-2760(73)90145-8.
8
Biochemical parameters correlated with tumour cell implantation.
Nature. 1973;246(5434):487-9. doi: 10.1038/246487a0.
9
Production of prostaglandins by cells in vitro: radioimmunoassay measurement of the conversion of arachidonic acid to PGE2 and PGF2 alpha.
Biochem Biophys Res Commun. 1973 Dec 10;55(3):724-9. doi: 10.1016/0006-291x(73)91204-7.
10
Environment of the blood-borne tumor embolus adherent to vessel wall.
J Med. 1973;4(3):150-77.
Zotero 插件